ZOE
PrivateLast Round
Series B
Extension
Jul 29, 2024
Est. Valuation
$332.5M
Total Funding Raised
$109.21M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ZOE operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series B Extension round in July 2024.
ZOE is a nutrition science company that provides personalized dietary plans and health insights through at-home medical testing services analyzing gut microbiome, blood fat, and blood sugar responses.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Subscription Commerce, Personalization
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZOE Comparables
Compare ZOE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viome Life Sciences | 84% | |
| Levels | 83% | |
| Signos | 79% |
For institutional investors. Book with your work email.
ZOE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 29, 2024 | ||||
| Series B Extension | Mar 15, 2023 | ||||
| Series B Extension | Dec 1, 2022 | ||||
| Series B | May 4, 2021 | ||||
| Series A | Jun 1, 2019 | ||||
Seed | Aug 17, 2018 |
For institutional investors. Book with your work email.
ZOE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coefficient Capital | Series B Extension |
| Accomplice | Series A, Series B, Series B Extension |
| Daphni | Series A, Series B, Series B Extension |
| L Catterton | Series B Extension |
| THVC | Series B |
| Ahren Innovation Capital | Series B Extension, Series B |
| Balderton Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2026
Head Nutritionist spoke at The Economist's Future of Health Europe event.
- Mar 4, 2026
Monthly visitors grew 49% MoM, reaching 18.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 4, 2026
ZOE Limited attends The Economist’s Future of Health Europe event on Nov 3rd '26, where its Head Nutritionist, Dr Federica Amati, highlights gaps in care surrounding GLP-1 therapies.
- launchesOct 27, 2026
ZOE Limited launches its Gut Health Bar in Massachusetts on Oct 27th '26, offering a science-designed snack with more than 10 plant ingredients, 8g of fiber, 7g of plant protein, and two flavors.
- identified_as_competitor_ofSep 29, 2026
In the supplement and personalized nutrition market, ZOE Limited is identified as a competitor of InsideTracker, as companies capitalize on demand for direct-to-consumer blood testing that maps dietary intake to metabolic markers.
For institutional investors. Book with your work email.
ZOE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ZOE's valuation, stock price, and market status.
Is ZOE a public or private company?
ZOE is a private company.
What is the current stock price of ZOE?
ZOE is a private company, so its shares have no public market price. Caplight tracks ZOE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ZOE worth (valuation)?
ZOE's valuation is estimated at $332.5M based on funding round data.
Can I buy ZOE stock?
ZOE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ZOE's last funding round?
ZOE's most recent funding round was Series B Extension on July 29, 2024.
Who are the main investors in ZOE?
Key investors in ZOE include Coefficient Capital, Accomplice, Ahren Innovation Capital.
Will ZOE IPO soon?
No public IPO plans have been announced for ZOE.
How can I track ZOE secondary market activity?
Caplight tracks bids, offers, and trades in ZOE's shares on secondary markets.